Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dibenzyl Trisulphide in Stage IV Cancers
NCT04113096Phase 1Unknown
- Sponsor
- The University of the West Indies
- Start
- Oct 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dibenzyl trisulfide in breast cancer, prostate cancer (PCa), Cervical Cancer (CC) and 1 more (4 cohorts), sponsored by The University of the West Indies. Primary endpoints: Prostate Cancer Response, Breast Cancer Response and 2 more. Status: unknown.
02
Drugs
dibenzyl trisulfide
03
Conditions
breast cancerprostate cancer (PCa)Cervical Cancer (CC)colon cancer
Beyond the preview
Go deeper on NCT04113096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113096.